David Planchard
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
David Planchard
Sep 7, 2024, 07:32 |
Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 27, 2024, 22:06 |
Insight
Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…
Jul 18, 2024, 10:05 |
Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
Jul 13, 2024, 11:17 |
Blog
David Planchard: New option in the 1st line strategy for NSCLC EGFRmut patients
David Planchard, Thoracic Oncologist at Gustave Roussy, shared on LinkedIn: "Great news, a new option…
Jun 27, 2024, 14:15 |
Blog
David Planchard: Nice post-ASCO24 at Gustave Roussy with the lung session
David Planchard shared on LinkedIn: "Nice post-ASCO24 Gustave Roussy with the lung session. What wonderful…
May 19, 2024, 06:05 |
Insight
Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Herbert Loong shared on X: "We have recently published our latest recommendations for NTRK fusion…
May 10, 2024, 14:48 |
Blog
Rémi Thiolet: Gustave Roussy had the honor to meet the PM of Egypt and Minister of Health and Population
Rémi Thiolet, International advisor and Head of International Affairs at Gustave Roussy, shared on LinkedIn:…
May 9, 2024, 06:46 |
Societies
12 Posts Not To Miss From The 3rd International Summit on Lung Cancer!
The 3rd International Summit on Lung Cancer (RomeLung24), organized by the International Association for the…
May 1, 2024, 10:06 |
Insight
David Planchard: Proud to present 1st results of ICARUS-Lung 01 study
David Planchard, Professor at the University of Paris-Saclay, posted on LinkedIn: “Superb oral session on…
Apr 23, 2024, 23:52 |
Blog
David Planchard: The new Medical Oncology department opened at the Gustave Roussy
David Planchard, Professor at the University of Paris-Saclay, posted on LinkedIn: “While we await the opening…
Apr 20, 2024, 06:18 |
Insight
New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer
Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…
Apr 20, 2024, 06:08 |
Insight
David Planchard: Some advances for our BRAF V600E NSCLC patients…Review to read at npj Journals
David Planchard, Professor at the University of Paris-Saclay, posted on X/Twitter: "Some advances for our BRAF…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Feb 27, 2024, 19:03 |
Blog
Humaid Al-Shamsi: We had the pleasure to share our experience with Prof. Planchard in treating 10 complex lung cancer cases
Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI), posted on LinkedIn: "With Prof. David Planchard…
Dec 12, 2023, 12:40 |
Societies
20 Posts Not To Miss From ESMO Asia Congress 2023
The ESMO Asia Congress 2023 took place in Singapore from 1 to 3 December. Our…
Nov 12, 2023, 17:56 |
Drugs
David Planchard: Thank you to the patients who actively participated in this research
David Planchard, Professor at the University Paris Saclay, posted on X/Twitter. "Proud to lead this…
Aug 22, 2023, 09:53 |
Blog
David Planchard: Amphitheater full, impressive and top organization by the ESMO staff.
Quoting David Planchard, Thoracic Oncologist and Head of Thoracic Cancer Group at Gustave Roussy, stated…
All:
17
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube